Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons.

Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM, Grayson BE, Perello M, Nillni EA, Grove KL, Cowley MA.

Cell Metab. 2007 Mar;5(3):181-94.

2.

Electrophysiological actions of peripheral hormones on melanocortin neurons.

Cowley MA, Cone R, Enriori P, Louiselle I, Williams SM, Evans AE.

Ann N Y Acad Sci. 2003 Jun;994:175-86. Review.

PMID:
12851314
3.

Leptin sensitive neurons in the hypothalamus.

Baskin DG, Hahn TM, Schwartz MW.

Horm Metab Res. 1999 May;31(5):345-50. Review.

PMID:
10422733
4.
5.
6.

Leptin and melanocortin signaling in the hypothalamus.

Bjørbaek C, Hollenberg AN.

Vitam Horm. 2002;65:281-311. Review.

PMID:
12481551
7.
8.
9.

Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity.

Pritchard LE, Turnbull AV, White A.

J Endocrinol. 2002 Mar;172(3):411-21. Review.

10.

Melanocortin signaling and anorexia in chronic disease states.

Wisse BE, Schwartz MW, Cummings DE.

Ann N Y Acad Sci. 2003 Jun;994:275-81. Review.

PMID:
12851326
11.

Central orchestration of peripheral nutrient partitioning and substrate utilization: implications for the metabolic syndrome.

Denis RG, Joly-Amado A, Cansell C, Castel J, Martinez S, Delbes AS, Luquet S.

Diabetes Metab. 2014 Jun;40(3):191-7. doi: 10.1016/j.diabet.2013.11.002. Epub 2013 Dec 11. Review.

PMID:
24332017
12.

Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes.

Mountjoy KG.

Biochem J. 2010 May 27;428(3):305-24. doi: 10.1042/BJ20091957. Review.

PMID:
20504281
13.

Role of the arcuate nucleus of the hypothalamus in regulation of body weight during energy deficit.

Sainsbury A, Zhang L.

Mol Cell Endocrinol. 2010 Mar 25;316(2):109-19. doi: 10.1016/j.mce.2009.09.025. Epub 2009 Oct 12. Review.

PMID:
19822185
14.

Hypothalamic melanocortin signaling and leptin resistance--perspective of therapeutic application for obesity-diabetes syndrome.

Masuzaki H, Tanaka T, Ebihara K, Hosoda K, Nakao K.

Peptides. 2009 Jul;30(7):1383-6. doi: 10.1016/j.peptides.2009.04.008. Epub 2009 Apr 23. Review.

PMID:
19394382
15.

Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.

Baltatzi M, Hatzitolios A, Tziomalos K, Iliadis F, Zamboulis Ch.

Int J Clin Pract. 2008 Sep;62(9):1432-40. doi: 10.1111/j.1742-1241.2008.01823.x. Review.

PMID:
18793378
16.

The MC4 receptor and control of appetite.

Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, de Krom M.

Br J Pharmacol. 2006 Dec;149(7):815-27. Epub 2006 Oct 16. Review.

17.

Central melanocortins and the regulation of weight during acute and chronic disease.

Marks DL, Cone RD.

Recent Prog Horm Res. 2001;56:359-75. Review.

PMID:
11237221
18.

Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery.

Zhang Y, Scarpace PJ.

Peptides. 2006 Feb;27(2):350-64. Epub 2005 Nov 4. Review.

PMID:
16274846
19.

Cachexia: lessons from melanocortin antagonism.

Deboer MD, Marks DL.

Trends Endocrinol Metab. 2006 Jul;17(5):199-204. Epub 2006 Jun 5. Review.

PMID:
16750633
20.

Role of neuropeptides in appetite regulation and obesity--a review.

Arora S, Anubhuti.

Neuropeptides. 2006 Dec;40(6):375-401. Epub 2006 Aug 28. Review.

PMID:
16935329

Supplemental Content

Support Center